silybin has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amirghofran, Z; Gharagozloo, M; Khoshdel, Z | 1 |
1 other study(ies) available for silybin and Leukemia, T-Cell
Article | Year |
---|---|
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Deferoxamine; DNA Replication; Dose-Response Relationship, Drug; Humans; Iron; Iron Chelating Agents; Jurkat Cells; Leukemia, T-Cell; Silybin; Silymarin; Time Factors | 2008 |